PODCAST · business
Catalysts in Science
by STAT Brand Studio
Catalysts in Science explores the ideas and leaders shaping the future of health care, medicine, and the life sciences. Scientists, executives, clinicians, and other experts discuss the breakthroughs, research, and decisions moving their fields forward. Episodes are produced by STAT Brand Studio as sponsored content.
Episodes
-
Fifteen years later, Undetectable = Untransmittable continues to shape HIV care
Fifteen years after the HIV Prevention Trials Network (HPTN) 052 study changed the understanding of HIV transmission, its influence continues to extend far beyond the clinic. In this conversation, Jared Baeten of Gilead reflects on how the landmark study gave rise to Undetectable =…
more -
New approaches for cancer’s toughest challenges
Advances in oncology are creating new opportunities to deliver more personalized care for patients. In this sponsored conversation, Dr. Mika Kakefuda Derynck, Senior Vice President and Therapeutic Area Head of Oncology at Gilead Sciences, and Dr. Gallia Levy, Senior Vice President and Global Head...
-
How unmet patient needs are shaping the next phase of cancer research
Oncology leaders Jackson Egen of Gilead Sciences and Priti Hegde of Kite, a Gilead company, discuss how unmet patient needs are shaping the next phase of cancer research. They explore how Gilead and Kite are approaching oncology across multiple fronts, drawing on advances in blood cancers and...
-
Could U.S. policy clinch China’s grip on biotech?
Drug pricing reforms were meant to protect patients — but they may also be reshaping where innovation happens. In this interview, John Stanford of Incubate explains how MFN price controls and regulatory uncertainty ripple through the biotech ecosystem, squeezing small innovators and pushing...
-
Astellas CEO talks transformative medicines driving growth
At the 2026 JPM Conference in San Francisco, Astellas President and CEO Naoki Okamura spoke with STAT Brand Studio Editor Jesse McQuarters about the company’s strategy and long-term vision as it enters an important phase in the company’s evolution. Astellas is taking a patient-centered approach…
more -
Bridging gaps in asthma care
People living with asthma understand that their environment affects their health, but they’re often left without the tools, guidance, or support to fully act on that knowledge. In this virtual event, Chiesi unveils findings from its recent Asthma Community Survey, which looks at this fundamental...
-
How proteomics and multi-omics are deepening our understanding of human health
In this collaborative episode of The Nucleus, Dr. John Overton, vice president and chief sequencing officer at Regeneron Genetics Center (RGC), joins STAT Brand Studio’s Jesse McQuarters to explore how integrating proteomics and multi-omics can deliver deeper insight into how diseases develop —…
more -
“Taking possibility back” across oncology’s toughest frontiers
What does it take to transform the outlook for patients facing some of the most difficult cancers? Dr. Dietmar Berger, Chief Medical Officer at Gilead Sciences, shares how the company is tackling urgent needs in triple negative breast cancer (TNBC) and pioneering the next generation of CAR-T...
-
Can provider education and smarter policy close the biosimilars gap?
Biosimilars are driving down drug costs, expanding access to critical treatments, and creating space for future innovation. In this episode, Linda Choi MacDonald, EVP and Global Head of Commercial at Samsung Bioepis, discusses the challenges slowing biosimilar development — and how policy…
more -
From research to advocacy: A new fellowship honors Stephen Harrison’s vision in MASH research
The sudden passing of Dr. Stephen Harrison in 2024 marked the loss of a visionary liver disease researcher and compassionate advocate. His legacy lives on through a new fellowship program that aims to educate and empower patient advocates in MASH. Led by the Fatty Liver Foundation with support…
more -
Supporting science from bench to bioproduction
What does it take to bring a new therapy from concept to commercialization? In this episode, STAT Brand Studio editor Jesse McQuarters speaks with Jerry Keybl, SVP for Biopharma Products and Strategy at Avantor, about how the company partners across the biotech and biopharma ecosystem to solve...
-
Building the future of life sciences in NYC
New York City is investing over $1 billion to become a global leader in the life sciences — and at the heart of that mission is a commitment to infrastructure, innovation, and equity. In this episode, STAT Brand Studio editor Jesse McQuarters speaks with Viq Pervaaz, senior vice president at...
-
Puerto Rico’s competitive edge: Workforce, incentives, and cutting-edge infrastructure
Puerto Rico is emerging as a key biopharma hub, offering advanced manufacturing capabilities, a highly skilled workforce, and significant cost advantages. In this conversation, OcyonBio CEO Robert Salcedo discusses how his company is leveraging AI-driven manufacturing, modular wet labs, and...
-
Fighting colorectal cancer disparities with real-world data
Colorectal cancer remains the second leading cause of cancer deaths, with disparities in screening and care access posing major challenges. At the 2024 STAT Summit, Dr. Angie Nicholas and Dr. Fola May discussed how real-world data and collaboration among diverse stakeholders is driving efforts to...
-
Three-year degree expands access to medical education and fast-tracks specialty study
NYU Grossman School of Medicine is transforming medical education with an innovative three-year medical degree and tuition-free enrollment. Senior Associate Dean Joan Cangiarella, M.D., highlights the school's commitment to curriculum reform and personalized learning pathways designed to equip...
-
Top-ranked health system launches wide-ranging molecular oncology program
Molecular testing tools, including tumor sequencing and increasingly sensitive diagnostics, are leveling up oncology by enabling precise, personalized cancer treatment. Clinicians can now detect circulating tumor DNA, assess patients' cancer risk, monitor for resistance mutations, and adjust...
-
Approaching patient care with understanding, respect, and humility
As CEO of NYU Langone Health and dean of the Grossman School of Medicine, Dr. Robert Grossman leads a health system that excels in patient-oriented metrics, with a strategic eye toward the future. In this STAT Brand Studio podcast, he details the organization's landmark accomplishments over the...
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Catalysts in Science explores the ideas and leaders shaping the future of health care, medicine, and the life sciences. Scientists, executives, clinicians, and other experts discuss the breakthroughs, research, and decisions moving their fields forward.
Episodes are produced by STAT Brand Studio as sponsored content.
HOSTED BY
STAT Brand Studio
Loading similar podcasts...